Content about Neuralgia

July 23, 2012

Pfizer pain drug doesn't affect sperm production, study finds

A drug made by Pfizer for treating pain disorders doesn't affect men's reproductive functions, according to a new post-approval clinical study.

July 5, 2012

FDA approves generic version of Lyrica

The Food and Drug Administration has approved Lupin Pharmaceuticals' generic version of a drug used to treat pain and seizure disorders.

June 21, 2012

FDA approves Lyrica for spinal pain

The Food and Drug Administration has approved a new indication for a Pfizer drug.

June 7, 2012

FDA approves GSK, XenoPort drug for shingles pain

The Food and Drug Administration has approved a drug made by GlaxoSmithKline and XenoPort for treating pain associated with shingles.

May 29, 2012

Watson settles with Endo, Teikoku Seiyaku over generic version of Lidoderm patch

Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.

April 12, 2012

Impax Labs files Gralise patent challenge

Generic drug maker Impax Labs is challenging the patent protection on a drug used to treat postherpetic neuralgia, the company said Thursday.

March 9, 2012

FDA committee to discuss anti-NGF drug class at meeting

A Food and Drug Administration panel will meet Monday to discuss a class of drugs designed to treat chronic painful conditions that currently are under development and the safety issues possibly related to the drugs.

December 15, 2011

FDA to review patch for HIV-related pain

A Food and Drug Administration expert panel will review a drug made by NeurogesX as a potential treatment for pain associated with HIV.

October 10, 2011

Depomed launches shingles drug

Depomed has launched a new drug for treating shingles, the drug maker said Monday.

August 11, 2011

GSK, XenoPort file sNDA for Horizant

Drug makers GlaxoSmithKline and XenoPort are seeking expanded approval for their restless legs syndrome treatment.

February 28, 2011

Matrix Labs' gabapentin capsules get FDA OK

The Food and Drug Administration has approved a treatment for shingles made by a subsidiary of generic drug maker Mylan.

February 22, 2011

Hi-Tech Pharmacal receives market exclusivity for generic Neurontin

Generic drug maker Hi-Tech Pharmacal has received Food and Drug Administration approval for its version of a drug used to treat neurological disorders, the company said Tuesday.

November 4, 2010

FDA approves Cymbalta for treating chronic musculoskeletal pain

The Food and Drug Administration has approved a new usage for a drug used to...

October 17, 2010

NeurogesX seeks expanded approval for Qutenza

A company that develops drugs for pain is hoping to get approval of one of...

March 30, 2010

Cobroxin to be featured on morning talk show

XenaCare announced Wednesday that its over-the-counter pain reliever, Cobroxin, will be featured on a segment...

March 21, 2010

Shingles drug may capture half the market, Decision Resources predicts

A once-a-day formulation of a Pfizer drug potentially could capture half of the market for...